Abstract:Objective Melanoma is one of the most immunogenic solid tumors, with strong metastatic characteristics. Although melanoma is curable when detected in a localized form, the long-term survival rates of patients are difficult to improve by any single therapy. The combination of photodynamic therapy ( PDT) and immunotherapy has shown encouraging therapeutic efficacy against various cancers due to PDT-induced immunogenic cell death. Natural killer (NK) cell-based immunotherapy has the ability to enhance the anticancer effects of PDT. The NK cell family 2 member D/ ligand (NKG2D/NKG2DL) pathway acts as a master switch in the activation of NK cells and mediates the recognition of tumor cells by NK cells. However, tumor cells can produce soluble NKG2DLs via shedding, which mediates the immune escape of tumors. Regulating NKG2D-related molecular pathways can effectively improve the anti-tumor efficacy of NK cells. Further, combined with PDT, NK-related anti-tumor immunity and therapeutic effects could be significantly promoted. In this study, a tumor microenvironment-and light-responsive nanoparticle-MMP-2-responsive polypeptide mixed liposome (MRPL-SC) -was designed to realize synergistic anti-tumor effects of Ce6-mediated PDT and SB-3CT enhanced NKG2D-based immunotherapy, and spatial-temporally controlled release of loaded drugs. Methods To synthesize MRPL-SC, DSPE-PEG(3400)-MRP-beta-CD with an MMP-2 cleavable sequence was formed via multistep reactions. Then, MRPL-SC, combined with beta-cyclodextrin (beta-CD) containing SB-3CT to suppress the overexpressed MMP-2 that is tightly associated with the tumor NK-related escape mechanism in the tumor microenvironment and photosensitizer Ce6-loaded liposomes, was prepared using the film dispersion and extrusion method. The multi-responsive release ability of SB-3CT triggered by the MMP-2 abundant tumor microenvironment and chlorin e6 (Ce6) by 660 nm laser irradiation was studied in vitro. Cellular uptake, ROS generation, and the synergistic anti-tumor effects of MRPL-SC-mediated PDT and enhanced NK immunotherapy were studied in A375 cells, followed by the analysis of NKG2DLs expression. In addition, the anti-tumor efficiency and safety of MRPL-SCs were studied in tumor-bearing nude BALB/c mouse models. Results and Discussions The prepared MRPL-SC exhibited a typical liposome structure with a phospholipid bilayer and formed single/double-layer vesicles for drug encapsulating and intracellular delivering with a particle size about 160. 170 nm ( Fig. 2). Then, the MMP-2-responsive polypeptide linker was hydrolyzed by MMP-2, and SB-3CT encapsulated in beta-CD was rapidly released, with accumulation reaching 72. 26% after 240 min, indicating the responsiveness of MRPL-SC to the MMP-2 abundant tumor extracellular microenvironment. The released SB-3CT effectively regulated the expression of NKG2DLs and generation of soluble NKG2DLs in tumor tissues by directly inhibiting MMP-2 in situ. Ce6-encapsulated liposomes entered the tumor cells through endocytosis and induced severe cytotoxicity by PDT under 660 nm laser irradiation (Fig. 5). In addition, Ce6-PDT also induced NKG2DLs expression, thereby realizing spatiotemporal synergistic enhancement of NK immunity in tumor tissues (Fig. 6). By employing the A375 tumor-bearing nude mice xenograft model, MRPL-SCs showed higher amounts of aggregation in tumor tissue and efficiently suppressed melanoma growth after laser irradiation (Fig. 8) without significant cytotoxic effects in the major organs. Conclusions In this study, a novel multi-responsive nanoliposome composed of photosensitizer Ce6-liposomes and MMP-2 antagonist SB-3CT linked by MMP-2 responsive peptide was successfully fabricated via film dispersion and extrusion. The synergistic anti-tumor effect of MRPL-SC-mediated PDT and NK cell immune enhancement was observed in both melanoma cells and nude mouse xenograft models. This study not only developed a new multi-responsive nanocomplex for better integration of PDT and immunotherapy but also elucidated a novel paradigm for NK cell-mediated photodynamic immunotherapy for melanoma.

Chlorin-Based Photoactivable Galectin-3-Inhibitor Nanoliposome for Enhanced Photodynamic Therapy and NK Cell-Related Immunity in Melanoma

Nanoliposomes co-encapsulating Ce6 and SB3CT against the proliferation and metastasis of melanoma with the integration of photodynamic therapy and NKG2D-related immunotherapy on A375 cells

Multi-Responsive Liposomal Nanocomplex Encapsulating Ce6 & MMP-2 Inhibitors for Photodynamic-Immune Synergistic Treatment of Melanoma

Targeted pH-Activated Peptide-Based Nanomaterials for Combined Photodynamic Therapy with Immunotherapy

Combination of GNRs-PEI/cGAMP-laden Macrophages-Based Photothermal Induced in Situ Tumor Vaccines and Immune Checkpoint Blockade for Synergistic Anti-Tumor Immunotherapy.

MMP-2 Inhibitor-Mediated Tumor Microenvironment Regulation Using a Sequentially Released Bio-Nanosystem for Enhanced Cancer Photo-Immunotherapy

Co-delivery of Bee Venom Melittin and a Photosensitizer with an Organic-Inorganic Hybrid Nanocarrier for Photodynamic Therapy and Immunotherapy

Dissolving Microneedles Loading TPGS Biphasic Functionalized PLGA Nanoparticles for Efficient Chemo‐Photothermal Combined Therapy of Melanoma

Photosensitizer-loaded gold nanocages for immunogenic phototherapy of aggressive melanoma

Natural Killer Cell Membrane Doped Supramolecular Nanoplatform with Immuno-Modulatory Functions for Immuno-Enhanced Tumor Phototherapy

Harnessing chlorin e6 loaded by functionalized iron oxide nanoparticles linked with glucose for target photodynamic therapy and improving of the immunogenicity of lung cancer

A Multifunctional Nanoparticle Dual Loading with Chlorin e6 and STING Agonist for Combinatorial Therapy of Melanoma

Near-infrared photothermal liposomal nanoantagonists for amplified cancer photodynamic therapy

Gelatinase-sensitive nanoparticles loaded with photosensitizer and STAT3 inhibitor for cancer photothermal therapy and immunotherapy

Photosensitizer-stabilized Self-Assembling Nanoparticles Potentiate Chemo/photodynamic Efficacy of Patient-Derived Melanoma.

High Affinity of Chlorin E6 to Immunoglobulin G for Intraoperative Fluorescence Image-Guided Cancer Photodynamic and Checkpoint Blockade Therapy

Sequentially Responsive Peptide Assembling Liposomes Integrating Photosensitizer and Immune Drug for Enhanced Photodynamic/immunotherapy in Skin Melanoma

Combined Cancer Chemo-Photodynamic and Photothermal Therapy Based on ICG/PDA/TPZ-Loaded Nanoparticles

Photosensitizer-loaded Biomimetic Platform for Multimodal Imaging-Guided Synergistic Phototherapy

Nano‐Mediated PDT as a Multifunctional Immunomodulatory Agent in the Intricate Milieu of Melanoma

Photothermal Therapy Mediated by Phase-Transformation Nanoparticles Facilitates Delivery of Anti-Pd1 Antibody and Synergizes with Antitumor Immunotherapy for Melanoma